148 related articles for article (PubMed ID: 35899618)
1. Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis.
Kuno T; Fujisaki T; Shoji S; Sahashi Y; Tsugawa Y; Iwagami M; Takagi H; Briasoulis A; Deharo P; Cuisset T; Latib A; Kohsaka S; Bhatt DL
Circ Cardiovasc Interv; 2022 Aug; 15(8):e011990. PubMed ID: 35899618
[TBL] [Abstract][Full Text] [Related]
2. De-escalation of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention: a systematic review and network meta-analysis.
De Filippo O; Piroli F; Bruno F; Bocchino PP; Saglietto A; Franchin L; Angelini F; Gallone G; Rizzello G; Ahmad M; Gasparini M; Chatterjee S; De Ferrari GM; D'Ascenzo F
BMJ Evid Based Med; 2024 May; 29(3):171-186. PubMed ID: 38242567
[TBL] [Abstract][Full Text] [Related]
3. Net clinical benefit of dual antiplatelet therapy in elderly patients with acute coronary syndrome: A systematic review and meta-analysis.
Fujisaki T; Kuno T; Iwagami M; Miyamoto Y; Takagi H; Deharo P; Cuisset T; Briasoulis A; Panaich S; Latib A; Kohsaka S
Catheter Cardiovasc Interv; 2023 Nov; 102(5):788-802. PubMed ID: 37675959
[TBL] [Abstract][Full Text] [Related]
4. An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
Natsuaki M; Watanabe H; Morimoto T; Yamamoto K; Obayashi Y; Nishikawa R; Ando K; Domei T; Suwa S; Ogita M; Isawa T; Takenaka H; Yamamoto T; Ishikawa T; Hisauchi I; Wakabayashi K; Onishi Y; Hibi K; Kawai K; Yoshida R; Suzuki H; Nakazawa G; Kusuyama T; Morishima I; Ono K; Kimura T
Circulation; 2024 Feb; 149(8):585-600. PubMed ID: 37994553
[TBL] [Abstract][Full Text] [Related]
5. De-escalation of Antiplatelet Therapy After Percutaneous Coronary Intervention in East Asian Patients With Acute Coronary Syndrome.
Li W; Zhou S; Zhang H; Wang Z; Mu G; Xie Q; Liu Z; Hua M; Cui Y; Xiang Q
Clin Ther; 2024 Feb; 46(2):114-121. PubMed ID: 38071131
[TBL] [Abstract][Full Text] [Related]
6. Preferred monotherapy after short-term dual antiplatelet therapy: Systematic review and network meta-analysis of randomized trials.
Shoji S; Kuno T; Ueyama H; Takagi H; Briasoulis A; Kim HS; Koo BK; Kang J; Watanabe H; Kimura T; Kohsaka S
J Cardiol; 2024 May; 83(5):338-347. PubMed ID: 37562542
[TBL] [Abstract][Full Text] [Related]
7. Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis.
Valgimigli M; Gragnano F; Branca M; Franzone A; da Costa BR; Baber U; Kimura T; Jang Y; Hahn JY; Zhao Q; Windecker S; Gibson CM; Watanabe H; Kim BK; Song YB; Zhu Y; Vranckx P; Mehta S; Ando K; Hong SJ; Gwon HC; Serruys PW; Dangas GD; McFadden EP; Angiolillo DJ; Heg D; Calabrò P; Jüni P; Mehran R;
JAMA Cardiol; 2024 May; 9(5):437-448. PubMed ID: 38506796
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized Trials.
Baber U; Jang Y; Oliva A; Cao D; Vogel B; Dangas G; Sartori S; Spirito A; Smith KF; Branca M; Collier T; Pocock S; Valgimigli M; Kim BK; Hong MK; Mehran R
Circulation; 2024 Feb; 149(8):574-584. PubMed ID: 37870970
[TBL] [Abstract][Full Text] [Related]
9. De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis.
Gorog DA; Ferreiro JL; Ahrens I; Ako J; Geisler T; Halvorsen S; Huber K; Jeong YH; Navarese EP; Rubboli A; Sibbing D; Siller-Matula JM; Storey RF; Tan JWC; Ten Berg JM; Valgimigli M; Vandenbriele C; Lip GYH
Nat Rev Cardiol; 2023 Dec; 20(12):830-844. PubMed ID: 37474795
[TBL] [Abstract][Full Text] [Related]
10. Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes-a substudy of the TROPICAL-ACS trial.
Komócsi A; Merkely B; Hadamitzky M; Massberg S; Rizas KD; Hein-Rothweiler R; Gross L; Trenk D; Sibbing D; Aradi D
Eur Heart J Cardiovasc Pharmacother; 2023 Nov; 9(7):608-616. PubMed ID: 37015874
[TBL] [Abstract][Full Text] [Related]
11. Dual Antiplatelet Therapy De-Escalation in Stabilized Myocardial Infarction With High Ischemic Risk: Post Hoc Analysis of the TALOS-AMI Randomized Clinical Trial.
Lee M; Byun S; Lim S; Choo EH; Lee KY; Moon D; Choi IJ; Hwang BH; Kim CJ; Park MW; Choi YS; Kim HY; Yoo KD; Jeon DS; Yim HW; Chang K;
JAMA Cardiol; 2024 Feb; 9(2):125-133. PubMed ID: 38117483
[TBL] [Abstract][Full Text] [Related]
12. De-Escalation of P2Y12 Receptor Inhibitor Therapy after Acute Coronary Syndromes in Patients Undergoing Percutaneous Coronary Intervention.
Kupka D; Sibbing D
Korean Circ J; 2018 Oct; 48(10):863-872. PubMed ID: 30238704
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Capodanno D; Di Maio M; Greco A; Bhatt DL; Gibson CM; Goette A; Lopes RD; Mehran R; Vranckx P; Angiolillo DJ
J Am Heart Assoc; 2020 Aug; 9(16):e017212. PubMed ID: 32805186
[TBL] [Abstract][Full Text] [Related]
14. Comparison efficacy and safety of different antiplatelet or anticoagulation drugs in chronic coronary syndromes patients: A Bayesian network meta-analysis.
Liu C; Ma L
Medicine (Baltimore); 2023 Dec; 102(48):e36429. PubMed ID: 38050293
[TBL] [Abstract][Full Text] [Related]
15. De-escalation from ticagrelor to clopidogrel in patients with acute myocardial infarction: the TALOS-AMI HBR substudy.
Kim MC; Ahn SG; Cho KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Lee JW; Youn YJ; Kim HY; Yoo KD; Jeon DS; Shin ES; Jeong YH; Chang K; Ahn Y
EuroIntervention; 2023 Dec; 19(10):e832-e843. PubMed ID: 37724337
[TBL] [Abstract][Full Text] [Related]
16. Balancing Benefits and Risks of Oral Antiplatelet Strategies in patients With Coronary Artery Diseases: An Evolving Issue.
De Luca L; Gragnano F; Calabrò P; Huber K
Curr Probl Cardiol; 2023 Dec; 48(12):102025. PubMed ID: 37553063
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y
Mathew RO; Sidhu MS; Rihal CS; Lennon R; El-Hajjar M; Yager N; Lyubarova R; Abdul-Nour K; Weitz S; O'Cochlain DF; Murthy V; Levisay J; Marzo K; Graham J; Dzavik V; So D; Goodman S; Rosenberg YD; Pereira N; Farkouh ME
Cardiovasc Drugs Ther; 2024 Jun; 38(3):447-457. PubMed ID: 36445624
[TBL] [Abstract][Full Text] [Related]
18. De-escalation of antithrombotic treatment after acute coronary syndrome, a new paradigm.
Rubboli A; Atar D; Sibbing D
Intern Emerg Med; 2024 Apr; ():. PubMed ID: 38594458
[TBL] [Abstract][Full Text] [Related]
19. Tailoring antiplatelet therapy in older patients with coronary artery disease.
Kovacevic M; Pompei G; Kunadian V
Platelets; 2023 Dec; 34(1):2285446. PubMed ID: 38050696
[TBL] [Abstract][Full Text] [Related]
20. Temporal variations in ischemic and bleeding event risks after acute coronary syndrome during dual antiplatelet therapy.
Fujii T; Kasai S; Kawamura Y; Yoshimachi F; Ikari Y
Int J Cardiol; 2023 Dec; 392():131340. PubMed ID: 37678433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
